Activity and Safety of Peptide-based Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck.

Clinical trial NCT04445064 · TERMINATED

Trial details

NCT number: NCT04445064
Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Oropharynx Squamous Cell Carcinoma Larynx Squamous Cell Carcinoma Hypopharynx Squamous Cell Carcinoma Oral Cavity Squamous Cell Carcinoma

Start date: 2020-08-14
Primary completion: 2024-06-08
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.